Boston Scientific nixes $230M M.I.Tech acquisition – Fierce Biotech
In a statement sent to Fierce Medtech on Thursday, Boston Scientific said the agreement “required global regulatory approvals that we were not able to …
In a statement sent to Fierce Medtech on Thursday, Boston Scientific said the agreement “required global regulatory approvals that we were not able to …
Based on recent headline ratings, 85% of this readership currently trusts the local media, which has an average score of 75% regionally and is currently trending neutrally.